A workforce on the surgical management of tricuspid endocarditis in patients who inject drugs cautioned against relying on vegetation size and microbiology as criteria for surgery in these patients.

Background: A 26-year-old man with known but untreated ventricular septal defect was admitted to the emergency ward with abdominal pain, fever and weight loss. Transthoracic echocardiography showed ...

Based on the finalized national coverage determination (NCD) for transcatheter tricuspid valve replacement, Medicare will cover the procedure when used for an FDA-approved indication, and ...

TCT 662: Percutaneous Mechanical Aspiration for Right-Sided Infective Endocarditis in People Who Inject Drugs and Those with Cardiovascular Implantable Electronic Devices: Insights From the CLEAR-IE ...

TCT 740: Transcatheter solution for a massive tricuspid regurgitation and refractory right side heart failure in a patient with a previous cardiac transplantation. Receive the the latest news, ...

The diagnosis of IE requires the integration of clinical, laboratory, and echocardiographic data. Fever is the most common clinical manifestation; however it may be absent in patients with congestive ...

Among Medicare beneficiaries, implantation was especially frequent for female patients and those undergoing tricuspid valve replacement with or without concomitant left-sided heart surgeries.

According to the NIH, about 1.6 million people in the U.S. suffer from a condition where the tricuspid valve does not ...

Tricuspid regurgitation develops when the tricuspid valve between the right atrium and right ventricle does not close properly. The tricuspid valve controls the blood flow from the right atrium to the ...

Heart valves allow blood to flow one way and prevent it from flowing in the wrong direction. The tricuspid valve controls blood flow between the right atrium and right ventricle. The bicuspid or ...